GSK 580299 vaccine
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for GSK 580299 vaccine, covering 2012-10-15 to 2018-12-17. Get the full timeline:
Most recent: Clinical Trial Update: Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study [Phase 3]